Please assess the completion status of the following clinical trial:

Trial Title: Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* histologically confirmed prostate cancer adenocarcinoma~* definitive radiotherapy for curative intent~* low or intermediate risk prostate cancer~* patient age ≥ 75 years~* given informed consent~Exclusion Criteria:~* chronic inflammatory bowel disease~* high risk prostate cancer~* lymph node or distant metastases~* unable to give informed consent

- Gender: MALE
- Minimum Age: 75 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hypofractionated radiotherapy (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).